Selective dopamine D₃ receptor antagonists. A decade of progress: 1997 – 2007

Author： Micheli Fabrizio Heidbreder Christian

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.18, Iss.8, 2008-08, pp. : 821-840

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dopamine D3 receptor antagonists: a patent review (2007 – 2012)

By Micheli Fabrizio Heidbreder Christian

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 3, 2013-03 ,pp. : 363-381

Informa Healthcare

Access to resources Recommend Favorite

Selective dopamine D4 receptor antagonists

By Sanner M.A.

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 4, 1998-04 ,pp. : 383-393

Informa Healthcare

Access to resources Recommend Favorite

Recent Advances in the Development of Dopamine D3 Receptor Agonists and Antagonists

Mini Reviews in Medicinal Chemistry, Vol. 1, Iss. 1, 2001-05 ,pp. : 89-99

Bentham Science Publishers

Access to resources Recommend Favorite

Bitropic D3 Dopamine Receptor Selective Compounds s Potential Antipsychotics

Current Pharmaceutical Design, Vol. 21, Iss. 26, 2015-01 ,pp. : 3700-3724

Bentham Science Publishers

Access to resources Recommend Favorite

The dopamine D 4 receptor: one decade of research

By Oak J.N. Oldenhof J. Van Tol H.H.M.

European Journal of Pharmacology, Vol. 405, Iss. 1, 2000-09 ,pp. : 303-327

Elsevier

Access to resources Recommend Favorite